+ All Categories
Home > Documents > Indian Pharma Ppt

Indian Pharma Ppt

Date post: 06-Mar-2015
Category:
Upload: sudhendu007
View: 319 times
Download: 4 times
Share this document with a friend
21
WELCOME TO INDIAN PHARMACEUTICAL INDUSTRY
Transcript
Page 1: Indian Pharma Ppt

WELCOME TO

INDIAN PHARMACEUTIC

AL INDUSTRY

Page 2: Indian Pharma Ppt

HISTORY CHARACTERISTIC FUTURE PROSPECTS POSITIONING DOMESTIC INDIAN PHARMA MARKET IMPORT & EXPORT INDIAN PHARMA MARKET TOP 10 PHARMA COMPANIES TOP 10 BRANDS FAST GROWING COMPANIES TOP 5 THERAPEUTIC SEGMENTS MERGER & AQUISITION

TOPICS

Page 3: Indian Pharma Ppt

2006 2007 2008 2009

10.23

12.56

16.42

21.04

YEAR WISE TURN OVERVALUE IN BILLION US$

HISTORY

Page 4: Indian Pharma Ppt

Highly fragmented with more than 20,000 registered units and 375 pharma companies.

Associated with severe price competition and government price control.

Presently growing at 8-9 % growth per annum

CHARACTERISTIC

Page 5: Indian Pharma Ppt

Educated work force & english is frequently used

53 years old democracy and having solid framework & strong financial market.

International pharma industry finding great opportunities in INDIA.

Committed to free market economy & globalization.

WHY ONLY INDIA?

Page 6: Indian Pharma Ppt

Year 2008-09:turn over is 21.04 billion US$. As per “INDIA PHARMA 2020” turn-over is

expected to reach 55 billion US$ in 2020. Domestic pharma-20 billion US$ Health care pharma- 31.59 billion US$ by

2020. So,india would really become a LUCRATIVE

destination for clinical trials.

FUTURE PROSPECTS

Page 7: Indian Pharma Ppt

INDIAN PHARMACEUTICAL INDUSTRY is the 3rd largest in the world in terms of VOLUME.

INDIAN PHARMACEUTICAL INDUSTRY is on the 14th position in terms of VALUE.

POSITIONING

Page 8: Indian Pharma Ppt

2007 2008 20090

2

4

6

8

10

12

14

16

18

20

SALES IN BILLION US$GROWTH IN %

DOMESTIC INDIAN MARKET

Page 9: Indian Pharma Ppt

2003 2004 2005 2006 2007 2008 2009

SALES IN BIL-LION US$

2.57 3.04 3.57 4.45 5.38 6.15 7.69

GROWTH % NaN 18.61 17.38 24.41 21.06 14.37 24.94

2.5

12.5

22.5

EXPORT INDIAN PAHRMA MARKET

Page 10: Indian Pharma Ppt

2003 2004 2005 2006 2007 2008 2009

0.57 0.590.63000000000

0001 0.9 1.17 1.35 1.714

7.02

42.07

30.14

15.18

26.87

SALES IN BILLION US$ GROWTH %

IMPORT INDIAN PHARMA MARKET

Page 11: Indian Pharma Ppt

AS MARCH’2007

1. RANBAXY2. DR.REDDY’S LAB3. CIPLA4. SUN PHARMA5. LUPIN LTD6. AUROBINDO PHARMA7. GSK8. ZYDUS CADILA9. AVENTIS10. IPCA LAB

TOP 10 INDIAN PHARMA COMPANY

Page 12: Indian Pharma Ppt

1. CIPLA2. RANBAXY3. DR.REDDY’S LAB4. SUN PHARMA5. LUPIN LTD6. AUROBINDO PHARMA7. PIRAMAL HEALTHCARE8. CADILA9. MATRIX10. WOCKHARDT

AS MARCH’2009

Page 13: Indian Pharma Ppt

BRAND NAME CONTENT NAME OF COMPANY

COREX Chlorpheniramine,codeine sulphate

PFIZER

VOVERAN Diclofenac NOVARTIS

PHENSEDYL Chlorpheniramine, codeine sulphate.

PIRAMAL

HUMAN MIXTARD Insulin NOVO NORDISK

LIV-52 Ayurvedic product HIMALAYA

TAXIM Cefotaxime ALKEM

ZIFI Cefixime FDC

AUGMENTIN Amoxicillin,clavunic acid

GSK

MOX Amoxicillin RANBAXY

ASTHALIN salbutamol CIPLA

TOP 10 INDIAN PHARMA BRANDSAT SEPTEMBER 2009

Page 14: Indian Pharma Ppt

BRAND NAME NAME OF COMPNAY

COMPOSITION INDICATION

LIPITOR PFIZER ATORVASTATIN HIGH CHOLESTEROL

PLAVIX SANOFI AVENTIS CLOPIDROGEL ATHEROSCLEROSIS

REMICADE MERCK & CO INFIXIMAB RHEUMATOID ARTHRITIS

ADVAIR GSK SALMETEROL FLUTICASONE

ASTHMA

ENBREL PFIZER ETANERCEPT JUVENILE IDIOPATHIC ARTHRITIS

TOP 5 GLOBAL BRANDS AT SEPTEMBER 2009

Page 15: Indian Pharma Ppt

NAME OF THE COMPANY GROWTH RATE

MANKIND 37 %

SUN PHARMA 26 %

ABBOTT 25 %

ZYDUS 24 %

ALKEM 23.8 %

PFIZER 23.6%

FAST GROWING COMPANYAT SEPTEMBER 2009

Page 16: Indian Pharma Ppt

SEGMENT 2006 2007 2008 2009

ANTI-INFECTIVE 43.7 49.7 56.9 64.3

GASTRO-INTESTINAL 27.1 30.5 34.1 38.9

CARDIO 25.3 28.2 30.3 36.5

PAIN/ANALGESIC 21.4 26.3 29.9 36.1

RESPIRATORY 22.9 25.8 28.4 34.6

TOP 5 THERAPEUTIC SEGMENTS

Page 17: Indian Pharma Ppt

MERGER:is defined as voluntary amalgamation of two firms on roughly equal terms into one new legal entity.

ACQUISITION:The purchase of one corporation by another,through either the purchase of its shares or the purchase of its assets.

MERGER & AQUISITION

Page 18: Indian Pharma Ppt

Effected by exchange of the pre-merger shares from the stock of the new firms.

To increase market shares,to gain access to promising new technologies,to achieve synergies in their operations.

To eliminate competition,reduce tax liabilities

But it is risky,because many things may go wrong with even a well laid plan to grow by AQUIRING.

REASONS FOR MERGERS & AQUISITION

Page 19: Indian Pharma Ppt

PRE MERGER COMPANY

POST MERGER COMPANY

YEAR

ASTRA,ZENECA GROUP ASTRA ZENECA 1999

RHONE LTD AVENTIS 2000

GLAXO WELCOME-SMITHKLINE BEECHAM

GSK 2000

SANDOZ NOVARTIS 1996

PFIZER-LAMBERT PFIZER 2000

PFIZER-PHARMACIA PFIZER 2003

SANOFI-AVENTIS SANOFI AVENTIS 2004

LIST OF MERGER & AQUISITION

Page 20: Indian Pharma Ppt

AQUIRED COMPANY AQUIRING COMPANY YEAR

RANBAXY DAICHI SANKYO 2008

WYETH PFIZER 2009

PIRAMAL HEALTHCARE ABBOTT 2010

PARAS RECKITT BENCKISER 2011

TEVA PHARMA SUN PHARMA 2011

LATEST AQUISITION

Page 21: Indian Pharma Ppt

Recommended